Bright Minds Shares Owned By Insiders vs. Current Valuation
| DRUG Stock | USD 38.59 3.26 9.23% |
For Bright Minds profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bright Minds to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bright Minds Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bright Minds's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bright Minds Biosciences over time as well as its relative position and ranking within its peers.
Bright |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Return On Assets (0.29) | Return On Equity (0.52) |
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bright Minds Biosciences Current Valuation vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bright Minds's current stock value. Our valuation model uses many indicators to compare Bright Minds value to that of its competitors to determine the firm's financial worth. Bright Minds Biosciences is rated # 5 in shares owned by insiders category among its peers. It is rated as one of the top companies in current valuation category among its peers reporting about 8,871,624 of Current Valuation per Shares Owned By Insiders. Comparative valuation analysis is a catch-all technique that is used if you cannot value Bright Minds by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Bright Current Valuation vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Bright Minds |
| = | 27.28 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Bright Minds |
| = | 242.02 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Bright Current Valuation vs Competition
Bright Minds Biosciences is rated as one of the top companies in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 447.21 Million. Bright Minds totals roughly 242.02 Million in current valuation claiming about 54% of equities under Health Care industry.
Bright Minds Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bright Minds, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bright Minds will eventually generate negative long term returns. The profitability progress is the general direction of Bright Minds' change in net profit over the period of time. It can combine multiple indicators of Bright Minds, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 4.9 M | 5.1 M | |
| Operating Income | -6.5 M | -6.8 M | |
| Income Before Tax | -6.6 M | -7 M | |
| Total Other Income Expense Net | -141.6 K | -134.5 K | |
| Net Loss | -13.5 M | -12.8 M | |
| Net Loss | -6.6 M | -7 M | |
| Income Tax Expense | -16.3 K | -15.5 K | |
| Net Loss | -6.6 M | -7 M | |
| Change To Netincome | 744.8 K | 548.8 K | |
| Net Loss | (2.28) | (2.39) | |
| Income Quality | 0.86 | 0.62 | |
| Net Income Per E B T | 0.91 | 0.80 |
Bright Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bright Minds. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bright Minds position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bright Minds' important profitability drivers and their relationship over time.
Use Bright Minds in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bright Minds position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will appreciate offsetting losses from the drop in the long position's value.Bright Minds Pair Trading
Bright Minds Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Bright Minds could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bright Minds when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bright Minds - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bright Minds Biosciences to buy it.
The correlation of Bright Minds is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bright Minds moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bright Minds Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bright Minds can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bright Minds position
In addition to having Bright Minds in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials ETFs Thematic Idea Now
Financials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
To fully project Bright Minds' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bright Minds Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bright Minds' income statement, its balance sheet, and the statement of cash flows.